Important Drug Safety Update from the MHRA on Valproate and pregnancy

24th April 2018

The MHRA have issued new guidance stating that Valproate medicines (Epilim▼, Depakote▼) are contraindicated in women and girls of childbearing potential unless a Pregnancy Prevention Programme is in place.

Read the full update here: https://www.gov.uk/drug-safety-update/valproate-medicines-epilim-depakote-contraindicated-in-women-and-girls-of-childbearing-potential-unless-conditions-of-pregnancy-prevention-programme-are-met

More News

New SCRIPT website now LIVE

We are delighted to launch our new website aimed at providing a fresh, visually appealing and intuitive user experience. This update shows our commitment to ensuring our website is modern, accessible and focused on the needs of our users. The new design includes: An...